| Autor: |
Qdaisat A; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Yeung SJ; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Rojas Hernandez CH; Section of Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Samudrala P; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Kamal M; Symptom Research Department, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Li Z; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA., Wechsler AH; Department of Emergency Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA. |
| Abstrakt: |
Intracranial hemorrhage (ICH) is a dreaded complication of both cancer and its treatment. To evaluate the characteristics and clinical outcomes of cancer patients with ICH, we identified all patients with ICH who visited The University of Texas MD Anderson Cancer Center emergency department between 1 September 2006 and 16 February 2016. Clinical and radiologic data were collected and compared. Logistic regression analyses were used to determine the association between clinical variables and various outcomes. During the period studied, 704 confirmed acute ICH cases were identified. In-hospital, 7-day, and 30-day mortality rates were 15.1, 11.4, and 25.6%, respectively. Hypertension was most predictive of intensive care unit admission (OR = 1.52, 95% CI = 1.09-2.12, p = 0.013). Low platelet count was associated with both in-hospital mortality (OR = 0.96, 95% CI = 0.94-0.99, p = 0.008) and 30-day mortality (OR = 0.98, 95% CI = 0.96-1.00, p = 0.016). Radiologic findings, especially herniation and hydrocephalus, were strong predictors of short-term mortality. Among known risk factors of ICH, those most helpful in predicting cancer patient outcomes were hypertension, low platelet count, and the presence of hydrocephalus or herniation. Understanding how the clinical presentation, risk factors, and imaging findings correlate with patient morbidity and mortality is helpful in guiding the diagnostic evaluation and aggressiveness of care for ICH in cancer patients. |
